Viewing nowPimasol Tablets 30 mg (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 202501620 · Approved 2025.06.30 · Insurance code 663608970
Treatment of essential hypertension
Essential hypertension refers to a condition in which blood pressure is persistently high. This medication helps regulate blood pressure in essential hypertension to prevent complications. It is mainly used in hypertensive patients and stabilizes blood pressure, thereby reducing the risk of cardiovascular diseases. Therefore, it is used for essential hypertension.
Essential hypertension Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks ~ 12 weeks. Elderly patients No initial dose adjustment is required for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, an initial dose of 30 mg of this medicine once daily is recommended. (Refer to Precautions for Use, 9. Administration to Elderly Patients.) Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams daily. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate to severe hepatic impairment (refer to Precautions for Use, 2. Patients Who Must Not Take This Medicine and 10. Administration to Patients with Hepatic Impairment). Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (Refer to Precautions for Use, 3. Patients Who Must Use This Medicine with Caution.)
Pediatric patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this drug or its components, pregnant or breastfeeding women, patients undergoing dialysis, those with moderate to severe liver dysfunction, patients with biliary obstruction, diabetic patients with certain kidney diseases, and those with genetic metabolic disorders such as lactose intolerance should not take this medication. Patients with a deficiency of blood volume or sodium, patients with impaired renal function, patients with renal artery hypertension, aortic stenosis, and primary aldosteronism must use this medication cautiously and administer it while closely monitoring their condition. During treatment, symptoms such as headaches and dizziness can occur frequently, and various side effects including liver function abnormalities, muscle stiffness, skin rashes, and low blood pressure have been reported rarely. Since this medication lowers blood pressure, symptoms of hypotension may occur if there is a lack of blood volume or sodium, so caution is required when starting or increasing the dosage. Furthermore, because hyperkalemia may occur, it is important to regularly check potassium levels in the blood. When used in combination with other antihypertensives or diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, and others, interactions may occur, so it is necessary to consult with a doctor or pharmacist. Pregnant or breastfeeding women should avoid taking this medication, and breastfeeding mothers should consult a specialist before taking it. The safety of this medication for children under the age of 18 has not been established, so its use is not recommended. No special dosage adjustment is needed for the elderly, but caution is required due to the potential for sensitive reactions. This medication should not be administered to patients with severe liver dysfunction and should be used cautiously in patients with mild or moderate liver dysfunction. In case of an overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, so immediate medical treatment is needed. This medication should be kept out of reach of children and should not be transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container that blocks light and is kept at room temperature, between 1 to 30 degrees Celsius. This way of storage helps maintain the effectiveness of the drug for a longer time.
Light green, round oval film-coated tablet with a division line on one side
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.